Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Roose, S. P. Search for Related Content PubMed Citation Articles by Roose, S. P. Geriatric Psychiatry Depression Antidepressants Related Article

Antidepressant Pharmacotherapy in the Treatment of Depression in the Very Old: A Randomized, Placebo-Controlled Trial

OBJECTIVE: This study determined the efficacy of antidepressant medication for the treatment of depression in the "old-old." METHOD: This randomized 8-week medication trial compared citalopram, 10–40 mg/day, to placebo in the treatment of patients 75 and older with unipolar depression. RESULTS: A total of 174 patients who were 58% women with a mean age of 79.6 years (SD=4.4) and a mean baseline Hamilton Depression Rating Scale score of 24.3 (SD=4.1) were randomly assigned to treatment at 15 sites. There was a main effect for site but not for treatment condition. The remission rate, defined as a final Hamilton depression scale score <10, was 35% for the citalopram and 33% for the placebo groups. However, patients with severe depression (baseline Hamilton depression scale score >24) tended to have a higher remission rate with medication than with placebo (35% versus 19%). CONCLUSIONS: In the oldest group of community-dwelling patients to be studied to date, medication was not more effective than placebo for the treatment of depression. However, given the considerable psychosocial support received by all patients, the placebo condition represents more than the ingestion of an inactive pill. Across sites, there was considerable range in response to medication, 18% to 82%, and to placebo, 16% to 80%.

Related Article:

In This Issue
Am J Psychiatry 2004 161: A62. [Full Text] [PDF]

This article has been cited by other articles:

				A. Qaseem, V. Snow, T. D. Denberg, M. A. Forciea, D. K. Owens, and for the Clinical Efficacy Assessment Subcommittee Using Second-Generation Antidepressants to Treat Depressive Disorders: A Clinical Practice Guideline from the American College of Physicians Ann Intern Med, November 18, 2008; 149(10): 725 - 733. [Abstract] [Full Text] [PDF]

				G. Gartlehner, B. N. Gaynes, R. A. Hansen, P. Thieda, A. DeVeaugh-Geiss, E. E. Krebs, C. G. Moore, L. Morgan, and K. N. Lohr Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians Ann Intern Med, November 18, 2008; 149(10): 734 - 750. [Abstract] [Full Text] [PDF]

				G. S. Alexopoulos Personalizing the Care of Geriatric Depression Am J Psychiatry, July 1, 2008; 165(7): 790 - 792. [Full Text] [PDF]

				J. A. Blumenthal, M. A. Babyak, P. M. Doraiswamy, L. Watkins, B. M. Hoffman, K. A. Barbour, S. Herman, W. E. Craighead, A. L. Brosse, R. Waugh, et al. Exercise and Pharmacotherapy in the Treatment of Major Depressive Disorder Psychosom Med, September 1, 2007; 69(7): 587 - 596. [Abstract] [Full Text] [PDF]

				J. Raskin, C. G. Wiltse, A. Siegal, J. Sheikh, J. Xu, J. J. Dinkel, B. T. Rotz, and R. C. Mohs Efficacy of Duloxetine on Cognition, Depression, and Pain in Elderly Patients With Major Depressive Disorder: An 8-Week, Double-Blind, Placebo-Controlled Trial Am J Psychiatry, June 1, 2007; 164(6): 900 - 909. [Abstract] [Full Text] [PDF]

				R. Cooper-Kazaz, J. T. Apter, R. Cohen, L. Karagichev, S. Muhammed-Moussa, D. Grupper, T. Drori, M. E. Newman, H. A. Sackeim, B. Glaser, et al. Combined Treatment With Sertraline and Liothyronine in Major Depression: A Randomized, Double-blind, Placebo-Controlled Trial Arch Gen Psychiatry, June 1, 2007; 64(6): 679 - 688. [Abstract] [Full Text] [PDF]

				S. M. Friedman, D. M. Steinwachs, H. Temkin-Greener, and D. B. Mukamel Informal caregivers and the risk of nursing home admission among individuals enrolled in the program of all-inclusive care for the elderly. Gerontologist, August 1, 2006; 46(4): 456 - 463. [Abstract] [Full Text] [PDF]

				D. Weintraub, D. Taraborelli, K. H. Morales, J. E. Duda, I. R. Katz, and M. B. Stern Escitalopram for Major Depression in Parkinson's Disease: An Open-Label, Flexible-Dosage Study J Neuropsychiatry Clin Neurosci, August 1, 2006; 18(3): 377 - 383. [Abstract] [Full Text] [PDF]

				C. F. Reynolds III, M. A. Dew, B. G. Pollock, B. H. Mulsant, E. Frank, M. D. Miller, P. R. Houck, S. Mazumdar, M. A. Butters, J. A. Stack, et al. Maintenance treatment of major depression in old age. N. Engl. J. Med., March 16, 2006; 354(11): 1130 - 1138. [Abstract] [Full Text] [PDF]

				F. E. Lotrich and B. G. Pollock Aging and Clinical Pharmacology: Implications for Antidepressants J. Clin. Pharmacol., October 1, 2005; 45(10): 1106 - 1122. [Abstract] [Full Text] [PDF]

				B. J. CARROLL Citalopram and the Curate's Egg in Geriatric Depression Am J Psychiatry, September 1, 2005; 162(9): 1762 - 1762. [Full Text] [PDF]

				ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB Evid. Based Med., June 1, 2005; 10(3): 94 - 94. [Full Text] [PDF]

				Antidepressants in the Very Old Journal Watch Women's Health, December 28, 2004; 2004(1228): 6 - 6. [Full Text]

				How Helpful Are Antidepressants for the Very Old? Journal Watch Psychiatry, December 23, 2004; 2004(1223): 1 - 1. [Full Text]

				J. Rosack `Negative' Clinical Trial Is Complex Creature Psychiatr News, December 17, 2004; 39(24): 31 - 31. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us